Related Experiment Videos
Hemodynamic and cineangiographic study before and after mitral valvuloplasty (Carpentier's technique)
Insights
Mitral valvuloplasty offers stable midterm results for patients with mitral valve issues. Early intervention before irreversible heart damage is recommended for optimal outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Physiology
Background:
- Mitral valve disease often involves annular deformities and leaflet abnormalities.
- Surgical intervention is frequently required to address these complex pathologies.
Purpose of the Study:
- To evaluate the midterm hemodynamic and functional outcomes of mitral valvuloplasty.
- To assess the efficacy of mitral valve repair techniques in patients with complex mitral valve disease.
Main Methods:
- Hemodynamic and angiocardiographic studies were conducted in 26 patients post-mitral valvuloplasty.
- Patients underwent prosthetic ring annuloplasty and leaflet repair as needed.
Main Results:
- Significant reductions in cardiothoracic ratio and pulmonary artery pressure were observed.
- Cardiac index normalized, and left ventricular volumes and mass decreased post-surgery.
- Most patients remained asymptomatic with minimal residual mitral insufficiency.
Conclusions:
- Mitral valvuloplasty yields good and stable midterm results.
- The procedure effectively improves cardiac function and reduces ventricular remodeling.
- Timely surgical intervention is crucial to prevent irreversible myocardial damage.
Abstract:
Hemodynamic studies were performed in 26 patients 2-60 months after mitral valvuloplasty (average 14 months). All patients but one had an annular deformity requiring prosthetic ring annuloplasty. In addition, 25 patients had prolapsed leaflet or restricted leaflet motion requiring specific techniques of repair. All patients were asymptomatic after operation. Significant residual mitral insufficiency was present in only five patients. Roentgenograms showed a reduction in cardiothoracic ratio, from 0.62 +/- 0.07 preoperatively to 0.53 +/- 0.06 postoperatively (p less than 0.001). Mean pulmonary artery pressure decreased from 30 +/- 12 mm Hg to 18 +/- 6 mm Hg (p less than 0.001) and cardiac index returned to normal (2.7 +/- 0.7 1/min/m2 vs 3.1 +/- 0.7 1/min/m2, p less than 0.02). Angiocardiographic studies showed that end-diastolic volume index returned to normal (148 +/- 41 cm3/m2 vs 89 +/- 23 cm3/m2, p less than 0.001), with significant decreases in end-systolic volume index ( 63 +/- 27 cm3/m2 vs 43 +/- 16 cm3/m2, p less than 0.001), left ventricular mass (114 +/- 28 g/m2 vs 88 +/- 20 g/m2, p less than 0.001), ejection fraction (58 +/- 11% vs 52 +/- 11%, p less than 0.02) and mean velocity of fiber shortening (1.19 +/- 0.36 circ/sec vs 1.01 +/- 0.24 circ/sec, p less than 0.05). We conclude that mitral valvuloplasty provides good and stable midterm results and that the operation should be performed before irreversible myocardial lesions occur.